Literature DB >> 23184441

Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study.

Arrigo F G Cicero, Sergio D'Addato, Alessandra Reggi, Giulio Marchesini Reggiani, Claudio Borghi.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23184441     DOI： 10.1007/s11739-012-0875-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  4 in total

Review 1.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

2.  Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

Authors:  Giorgio Bedogni; Lucia Miglioli; Flora Masutti; Claudio Tiribelli; Giulio Marchesini; Stefano Bellentani
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

3.  A simple index of lipid overaccumulation is a good marker of liver steatosis.

Authors:  Giorgio Bedogni; Henry S Kahn; Stefano Bellentani; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2010-08-25       Impact factor: 3.067

4.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.

Authors:  Jeong-Hoon Lee; Donghee Kim; Hwa Jung Kim; Chang-Hoon Lee; Jong In Yang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sang-Heon Cho; Myung-Whun Sung; Hyo-Suk Lee
Journal:  Dig Liver Dis       Date:  2009-09-18       Impact factor: 4.088
  4 in total
  10 in total

Review 1.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

2.  Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martina Rosticci; Alessandra Reggi; Giuseppe Derosa; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-12-16

3.  Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.

Authors:  Chenxi Wang; Zhensheng Cai; Xia Deng; Haoxiang Li; Zhicong Zhao; Chang Guo; Panpan Zhang; Lian Li; Tian Gu; Ling Yang; Li Zhao; Dong Wang; Guoyue Yuan
Journal:  Int J Med Sci       Date:  2021-07-23       Impact factor: 3.738

4.  Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial.

Authors:  Arrigo F G Cicero; Federica Fogacci; Marilisa Bove; Marina Giovannini; Claudio Borghi
Journal:  Eur J Nutr       Date:  2020-05-16       Impact factor: 5.614

5.  Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial.

Authors:  Arrigo F G Cicero; Martina Rosticci; Angelo Parini; Martino Morbini; Riccardo Urso; Elisa Grandi; Claudio Borghi
Journal:  Nutr J       Date:  2015-03-28       Impact factor: 3.271

6.  Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.

Authors:  Arrigo F G Cicero; Martino Morbini; Angelo Parini; Riccardo Urso; Martina Rosticci; Elisa Grandi; Claudio Borghi
Journal:  Ther Clin Risk Manag       Date:  2016-02-23       Impact factor: 2.423

7.  Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.

Authors:  Arrigo F G Cicero; Federica Fogacci; Marilisa Bove; Maddalena Veronesi; Manfredi Rizzo; Marina Giovannini; Claudio Borghi
Journal:  Adv Ther       Date:  2017-07-07       Impact factor: 3.845

8.  Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system.

Authors:  Mao-Meng Tiao; Yu-Ju Lin; Hong-Ren Yu; Jiunn-Ming Sheen; I-Chun Lin; Yun-Ju Lai; You-Lin Tain; Li-Tung Huang; Ching-Chou Tsai
Journal:  Lipids Health Dis       Date:  2018-07-28       Impact factor: 3.876

9.  Prevalent Seasoning and Cooking Fats, Arterial Stiffness and Blood Lipid Pattern in a Rural Population Sample: Data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Federica Fogacci; Elisa Grandi; Elisabetta Rizzoli; Marilisa Bove; Sergio D'Addato; Claudio Borghi
Journal:  Nutrients       Date:  2020-10-07       Impact factor: 5.717

10.  Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study.

Authors:  Xintian Cai; Jing Gao; Shasha Liu; Mengru Wang; Junli Hu; Jing Hong; Qing Zhu; Guzailinuer Tuerxun; Yujie Dang; Nanfang Li
Journal:  Dis Markers       Date:  2022-08-03       Impact factor: 3.464
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.